PHYSOSTIGMINE ANTAGONIZES MORPHINE-INDUCED RESPIRATORY DEPRESSION BUT NOT ANALGESIA IN DOGS AND RABBITS

Open Access
Publisher Website
Google Scholar
Abstract
The ability of physostigmine to antagonize the respiratory depressant effect of morphine was studied in conscious rabbits and ketamine-anaesthetized dogs pretreated with atropine methyl nitrate. Morphine 4 mg kg−1 increased Paco2 in the rabbit from 3.43 ±0.16 to 4.95 ±0.28 kPa, decreased arterial pH from 7.45±0.01 to 7.31 ±0.01 and decreased respiratory frequency by 36%. Physostigmine 0.1 mgkg−1 reduced Paco2 to control values within 10 min and significantly increased arterial pH and respiratory frequency. There was no antagonism of the analgesic effect of morphine. Neostigmine 0.1 mg kg−1 did not reverse the respiratory depressant effect of morphine. In dogs anaesthetized with ketamine, morphine 15 mg kg−1 caused loss of consciousness and marked analgesia, decreased the respiratory frequency by 47%, and increased Paco2 by 47%. Physostigmine 0.1 mg kg−1 antagonized the effect of morphine on respiration and restored consciousness in the dogs, but did not impair analgesia. It is concluded that physostigmine reverses morphine-induced respiratory depression by prolonging the effect of acetyl-cholinc released from brain-stem neurones. The possibility should be considered of replacing opiate antagonists by physostigmine to reverse postoperative respiratory depression and drowsiness induced by opiates.